Búsqueda | Portal de Búsqueda de la BVS España

1.

Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients.

Avdeeva, A S; Cherkasova, M V; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 187-194, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833605

2.

Contributing Factors of Diabetes Mellitus among Patients with Gout (Results of the Long-Term Prospective Study).

Zheliabina, O V; Eliseev, M S; Glukhova, S I; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 195-202, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833606

3.

Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus.

Cheldieva, F A; Reshetnyak, T M; Shumilova, A A; Nurbaeva, K S; Cherkasova, M V; Lila, A M; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 227-234, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833610

4.

Antibodies to Domain I ß₂-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Reshetnyak, T M; Cheldieva, F A; Cherkasova, M V; Glukhova, S I; Lila, A M; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 219-226, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833609

5.

Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis.

Ananyeva, L P; Garzanova, L A; Koneva, O A; Starovoytova, M N; Desinova, O V; Ovsyannikova, O B; Shayakhmetova, R U; Cherkasova, M V; Aleksankin, A P; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 212-218, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833608

6.

Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?

Amirdzhanova, V N; Karateev, A E; Pogozheva, E Yu; Filatova, E S; Samigullina, R R; Mazurov, V I; Anoshenkova, O N; Lapkina, N A; Baranov, A A; Grineva, T Yu; Lila, A M; Nasonov, E L.

Dokl Biochem Biophys; 511(1): 180-186, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-37833604

7.

[Autoimmunity in rheumatology: A review].

Nasonov, E L.

Ter Arkh; 95(12): 1056-1063, 2023 Dec 28.

Artículo en Ruso | MEDLINE | ID: mdl-38158939

8.

[Hypogonadism syndrome in men with inflammatory joint diseases: A review].

Panevin, T S; Rozhivanov, R V; Nasonov, E L.

Ter Arkh; 95(5): 429-434, 2023 Jul 16.

Artículo en Ruso | MEDLINE | ID: mdl-38158997

9.

[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future].

Nasonov, E L; Reshetnyak, T M; Solovyev, S K; Popkova, T V.

Ter Arkh; 95(5): 365-374, 2023 Jul 16.

Artículo en Ruso | MEDLINE | ID: mdl-38158987

10.

[Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk].

Gerasimova, E V; Popkova, T V; Shalygina, M V; Kirillova, I G; Gerasimova, D A; Glukhova, S I; Nasonov, E L.

Ter Arkh; 95(5): 375-379, 2023 Jul 16.

Artículo en Ruso | MEDLINE | ID: mdl-38158988

11.

[A new integral enthesial-comorbididity index of psoriatic arthritis activity].

Korsakova, Y L; Korotaeva, T V; Loginova, E Y; Gubar, E E; Vorobyeva, L D; Glukhova, S I; Nasonov, E L.

Ter Arkh; 95(5): 404-409, 2023 Jul 16.

Artículo en Ruso | MEDLINE | ID: mdl-38158993

12.

[Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients].

Reshetnyak, T M; Lisitsyna, T A; Cheldieva, F A; Shumilova, A A; Glukhova, S I; Starovoytova, M N; Seredavkina, N V; Desinova, O V; Verizhnikova, Z G; Nasonov, E L.

Ter Arkh; 95(5): 410-417, 2023 Jul 16.

Artículo en Ruso | MEDLINE | ID: mdl-38158994

13.

[Janus kinase inhibitors in immunoinflammatory rheumatic diseases].

Nasonov, E L.

Ter Arkh; 94(5): 605-609, 2022 Jun 17.

Artículo en Ruso | MEDLINE | ID: mdl-36286957

14.

[Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review].

Nasonov, E L.

Ter Arkh; 94(8): 999-1005, 2022 Oct 12.

Artículo en Ruso | MEDLINE | ID: mdl-36286981

15.

[Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome].

Reshetnyak, T M; Cheldieva, F A; Cherkasova, M V; Lila, A M; Nasonov, E L.

Ter Arkh; 94(5): 628-634, 2022 Jun 17.

Artículo en Ruso | MEDLINE | ID: mdl-36286961

16.

[Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results].

Galushko, E A; Gordeev, A V; Matyanova, E V; Olyunin, Y A; Nasonov, E L.

Ter Arkh; 94(5): 661-666, 2022 Jun 17.

Artículo en Ruso | MEDLINE | ID: mdl-36286966

17.

[The burden of progression of psoriatic arthritis. All-Russian register data].

Korsakova, Y L; Loginova, E Y; Korotaeva, T V; Gubar, E E; Glukhova, S I; Vasilenko, E A; Nasonov, E L.

Ter Arkh; 94(5): 622-627, 2022 Jun 17.

Artículo en Ruso | MEDLINE | ID: mdl-36286960

18.

[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis].

Abramkin, A A; Lisitsyna, T A; Veltishchev, D Y; Seravina, O F; Kovalevskaya, O B; Glukhova, S I; Nasonov, E L.

Ter Arkh; 94(5): 616-621, 2022 Jun 17.

Artículo en Ruso | MEDLINE | ID: mdl-36286959

19.

Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis.

Fomicheva, O A; Popkova, T V; Krougly, L B; Gerasimova, E V; Novikova, D S; Pogorelova, O A; Tripoten, M I; Balakhonova, T V; Karpov, Yu A; Nasonov, E L.

Kardiologiia; 61(1): 12-21, 2021 Feb 10.

Artículo en Ruso, Inglés | MEDLINE | ID: mdl-33734051

20.

[2019 Coronavirus disease (COVID-19): contribution of rheumatology].

Nasonov, E L.

Ter Arkh; 93(5): 71504, 2021 May 15.

Artículo en Ruso | MEDLINE | ID: mdl-36286708

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Different Clinical Relevance of Anti-Citrullinated Protein Antibodies in RA Patients.

Contributing Factors of Diabetes Mellitus among Patients with Gout (Results of the Long-Term Prospective Study).

Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus.

Antibodies to Domain I ß₂-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis.

Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?

[Autoimmunity in rheumatology: A review].

[Hypogonadism syndrome in men with inflammatory joint diseases: A review].

[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future].

[Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk].

[A new integral enthesial-comorbididity index of psoriatic arthritis activity].

[Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients].

[Janus kinase inhibitors in immunoinflammatory rheumatic diseases].

[Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review].

[Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome].

[Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results].

[The burden of progression of psoriatic arthritis. All-Russian register data].

[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis].

Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis.

[2019 Coronavirus disease (COVID-19): contribution of rheumatology].